Interestingly, we classified one case (patient P0013) as basal-like but the pathology report labeled the case as ER+/PR-/HER2– based on IHC, though only 10 % of the tumor nuclei stained positive for ER and ER staining was weak (1+). Here, ERBB2 is linked to neoplasm.